| pubmed-article:14713279 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14713279 | lifeskim:mentions | umls-concept:C0014442 | lld:lifeskim |
| pubmed-article:14713279 | lifeskim:mentions | umls-concept:C1330957 | lld:lifeskim |
| pubmed-article:14713279 | lifeskim:mentions | umls-concept:C0020855 | lld:lifeskim |
| pubmed-article:14713279 | lifeskim:mentions | umls-concept:C0004358 | lld:lifeskim |
| pubmed-article:14713279 | lifeskim:mentions | umls-concept:C0038304 | lld:lifeskim |
| pubmed-article:14713279 | lifeskim:mentions | umls-concept:C0271737 | lld:lifeskim |
| pubmed-article:14713279 | lifeskim:mentions | umls-concept:C0596311 | lld:lifeskim |
| pubmed-article:14713279 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:14713279 | pubmed:dateCreated | 2004-1-9 | lld:pubmed |
| pubmed-article:14713279 | pubmed:abstractText | Immunoglobulin G (IgG) antibodies to the steroidogenic enzymes 21-hydroxylase (21OH) and side-chain cleavage enzyme (SCC) are important diagnostic markers for autoimmune Addison's disease and autoimmune polyendocrine syndromes (APS) types I and II. The characterization of autoantibody (IgG) subclasses may reveal information on how tIssue destruction takes place; therefore, IgG subtypes of anti-21OH and anti-SCC antibodies from sera of patients with Addison's disease, APS I and APS II were determined using recombinant 21OH and SCC. | lld:pubmed |
| pubmed-article:14713279 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14713279 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14713279 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14713279 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14713279 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14713279 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14713279 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14713279 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14713279 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14713279 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:14713279 | pubmed:issn | 0804-4643 | lld:pubmed |
| pubmed-article:14713279 | pubmed:author | pubmed-author:MellgrenGunna... | lld:pubmed |
| pubmed-article:14713279 | pubmed:author | pubmed-author:HusebyeEystei... | lld:pubmed |
| pubmed-article:14713279 | pubmed:author | pubmed-author:WinqvistOlaO | lld:pubmed |
| pubmed-article:14713279 | pubmed:author | pubmed-author:KämpeOlleO | lld:pubmed |
| pubmed-article:14713279 | pubmed:author | pubmed-author:BøeAnette SAS | lld:pubmed |
| pubmed-article:14713279 | pubmed:author | pubmed-author:KnappskogPer... | lld:pubmed |
| pubmed-article:14713279 | pubmed:author | pubmed-author:BredholtGeirG | lld:pubmed |
| pubmed-article:14713279 | pubmed:author | pubmed-author:HjelmervikTro... | lld:pubmed |
| pubmed-article:14713279 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14713279 | pubmed:volume | 150 | lld:pubmed |
| pubmed-article:14713279 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14713279 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14713279 | pubmed:pagination | 49-56 | lld:pubmed |
| pubmed-article:14713279 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:14713279 | pubmed:meshHeading | pubmed-meshheading:14713279... | lld:pubmed |
| pubmed-article:14713279 | pubmed:meshHeading | pubmed-meshheading:14713279... | lld:pubmed |
| pubmed-article:14713279 | pubmed:meshHeading | pubmed-meshheading:14713279... | lld:pubmed |
| pubmed-article:14713279 | pubmed:meshHeading | pubmed-meshheading:14713279... | lld:pubmed |
| pubmed-article:14713279 | pubmed:meshHeading | pubmed-meshheading:14713279... | lld:pubmed |
| pubmed-article:14713279 | pubmed:meshHeading | pubmed-meshheading:14713279... | lld:pubmed |
| pubmed-article:14713279 | pubmed:meshHeading | pubmed-meshheading:14713279... | lld:pubmed |
| pubmed-article:14713279 | pubmed:meshHeading | pubmed-meshheading:14713279... | lld:pubmed |
| pubmed-article:14713279 | pubmed:meshHeading | pubmed-meshheading:14713279... | lld:pubmed |
| pubmed-article:14713279 | pubmed:meshHeading | pubmed-meshheading:14713279... | lld:pubmed |
| pubmed-article:14713279 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:14713279 | pubmed:articleTitle | Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1. | lld:pubmed |
| pubmed-article:14713279 | pubmed:affiliation | Division of Endocrinology, Institute of Medicine, Haukeland University Hospital, N-5021, Bergen, Norway. Anette.Boe@med.uib.no | lld:pubmed |
| pubmed-article:14713279 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14713279 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
